Skip to content
PubMed This is a summary of 66 peer-reviewed journal articles Updated
Immunology · Good Syndrome

Good Syndrome: A Patient Guide

At a Glance

Good syndrome combines a thymoma with lasting immune-system problems: the body has very few antibody-making B cells and impaired T cells. Tumor removal may not restore immunity, so long-term IVIG or SCIG and close monitoring for infections and lung damage are often needed.

Good syndrome is a rare and complex medical condition that presents a unique dual challenge: the presence of a thymoma (a tumor of the thymus gland) and a profound, acquired immunodeficiency [1]. In this syndrome, the body’s immune defenses fail on two fronts. First, patients typically have markedly reduced or absent circulating B cells, the specialized white blood cells responsible for creating life-saving antibodies. Second, patients develop defects in T cells, which coordinate the immune response [2]. While the exact mechanism linking the thymoma to the lack of B cells (which develop in the bone marrow) is not fully understood, this combination leaves you highly vulnerable to a wide range of bacterial, viral, fungal, and opportunistic infections [3].

One of the most important things to understand about Good syndrome is that while the tumor and the immune deficiency are linked, they require separate and ongoing management. Undergoing surgery to remove the thymoma—which is standard for many resectable thymomas—does not reset or cure the immune system [4]. The immune defect is typically long-term or lifelong, meaning that even after a successful surgery, you will remain at high risk for infections [5].

Because of this, standard care often involves long-term immunoglobulin replacement therapy (IVIG or SCIG), where antibodies from healthy donors are infused into your body [6]. It is important to know that these infusions only replace antibodies; they do not correct the underlying T-cell dysfunction or guarantee protection from certain opportunistic viruses and fungi.

Living well with Good syndrome requires a shift in focus toward long-term protection and vigilance. A primary goal of your care team will be to minimize your infection burden to prevent permanent complications, particularly in your lungs [7]. Repeated bouts of pneumonia can lead to permanent scarring and widening of the airways (bronchiectasis), so protecting your respiratory health is a top priority [8]. To achieve this, you will work with a multidisciplinary team of specialists—including immunologists, oncologists, and pulmonologists—who monitor both the risk of the tumor returning and the effectiveness of your immune support [9].

While a diagnosis of Good syndrome is significant and life-altering, it is a condition that can be managed through careful coordination. By staying consistent with your infusions and maintaining close contact with your specialists, you can take control of your health and reduce the impact of the syndrome on your daily life. Your journey is one of careful balance, focusing on treating the tumor while methodically supporting your body’s defenses [10].

Common questions in this guide

What is Good syndrome?
Good syndrome is a rare condition in which a thymus tumor called a thymoma occurs with acquired immune deficiency. People often have very low or absent antibody-making B cells plus impaired T cells, which increases the risk of bacterial, viral, fungal, and other opportunistic infections.
Will removing my thymoma cure Good syndrome?
No. Surgery can remove the thymoma when it is resectable, but it usually does not reset the immune system. Infection risk and the need for immune support may continue long term, even after successful surgery.
Why might I need IVIG or SCIG for Good syndrome?
IVIG and SCIG provide antibodies collected from healthy donors to help replace the protection your body is not making. They do not correct T-cell problems and may not fully protect against some viruses and fungi, so other infection precautions remain important.
How can Good syndrome affect my lung health?
Repeated pneumonia and other respiratory infections can permanently scar and widen the airways, a condition called bronchiectasis. Lung monitoring and a prompt plan for new infections can help your care team reduce the risk of lasting damage.
Which doctors usually help manage Good syndrome?
Care is often coordinated among an immunologist, oncologist, and pulmonologist. The team can support antibody replacement, watch for thymoma recurrence, and monitor lung health and infection risk.
What should I do if I develop a cold or low-grade fever?
Contact your care team promptly and follow the individualized instructions they have given you, because even minor infections can become serious when immune defenses are impaired. Your clinicians can explain when you need urgent assessment and which treatments are appropriate for your immune profile.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who will be the primary coordinator between my oncology and immunology teams?
  2. 2.What are the specific steps I should take if I develop even a minor cold or low-grade fever?
  3. 3.How do we monitor my lung health to prevent permanent damage like bronchiectasis?
  4. 4.Based on my specific immune profile, what medications or activities should I avoid to stay safe?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Prevention of infectious diseases in patients with Good syndrome.

    Multani A, Gomez CA, Montoya JG

    Current opinion in infectious diseases 2018; (31(4)):267-277 doi:10.1097/QCO.0000000000000473.

    PMID: 29878906
  2. 2

    In-depth blood immune profiling of Good syndrome patients.

    Torres-Valle A, Aragon L, Silva SL, et al.

    Frontiers in immunology 2023; (14()):1285088 doi:10.3389/fimmu.2023.1285088.

    PMID: 38035080
  3. 3

    Understanding the uncommon: Insights into thymoma associated immunodeficiency.

    Lim XR, Leung BPL, Tan ETM, et al.

    Asian Pacific journal of allergy and immunology 2026; (44(2)):383-391 doi:10.12932/AP-080724-1887.

    PMID: 39955639
  4. 4

    Pure Red Cell Aplasia and Other Haematological Diseases Associated With Thymoma: A Case Series and Systematic Review.

    Yen CC, Huang WL, Li SS, et al.

    Frontiers in medicine 2021; (8()):759914 doi:10.3389/fmed.2021.759914.

    PMID: 34966753
  5. 5

    Clinical Characteristics, Surgical Risks, and Long-Term Prognosis of Good's Syndrome.

    Otsuka S, Shiiya H, Sasaki A, et al.

    Cureus 2026; (18(6)):e111036 doi:10.7759/cureus.111036.

    PMID: 42491992
  6. 6

    Features and outcomes of immunoglobulin therapy in patients with Good syndrome at Thailand's largest tertiary referral hospital.

    Thongngarm T, Boonyasiri A, Pradubpongsa P, et al.

    Asian Pacific journal of allergy and immunology 2019; (37(2)):109-115 doi:10.12932/AP-131117-0196.

    PMID: 29888926
  7. 7

    When the Good Syndrome Goes Bad: A Systematic Literature Review.

    Shi Y, Wang C

    Frontiers in immunology 2021; (12()):679556 doi:10.3389/fimmu.2021.679556.

    PMID: 34113351
  8. 8

    Good syndrome combined with multiple microbial pulmonary infections: case report and review of the literature.

    Ye Y, Wang J, Bao B, et al.

    Immunologic research 2024; (72(6)):1288-1298 doi:10.1007/s12026-024-09528-y.

    PMID: 39180607
  9. 9

    Immunodeficiency and thymoma in Good syndrome: Two sides of the same coin.

    Guevara-Hoyer K, Fuentes-Antrás J, Calatayud Gastardi J, Sánchez-Ramón S

    Immunology letters 2021; (231()):11-17 doi:10.1016/j.imlet.2020.12.010.

    PMID: 33418010
  10. 10

    Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).

    Zaman M, Huissoon A, Buckland M, et al.

    Clinical and experimental immunology 2019; (195(1)):132-138 doi:10.1111/cei.13216.

    PMID: 30216434

This page explains Good syndrome and its long-term immune and infection-management needs for informational purposes only; it does not replace medical advice. Your immunologist, oncologist, and pulmonologist should guide care for your specific situation.

Get notified when new evidence is published on Thymoma-hypogammaglobulinemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.